EZZ Life Science Holdings Ltd
Research EZZ Life Science Holdings Ltd (EZZ) on Bullrun: market cap AUD 17.42M, P/E 6.0, dividend yield 10.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEZZ
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyAUD
- Market capAUD 17.42M
- P/E6.0
- Dividend yield10.5%
- Financial periodFY2025
- RevenueAUD 66.87M
- Revenue growth0.6%
- Net incomeAUD 6.73M
- Free cash flowAUD 4.09M
- Gross margin74.3%
Valuation Snapshot
latest market cap is AUD 17.42M; P/E is 6.0; dividend yield is 10.5%.
About EZZ Life Science Holdings Ltd
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand.
Frequently asked questions
What is EZZ Life Science Holdings Ltd's market cap?
EZZ Life Science Holdings Ltd's market capitalization is AUD 17.42M.
What is EZZ Life Science Holdings Ltd's P/E ratio?
EZZ Life Science Holdings Ltd's price-to-earnings (P/E) ratio is 6.0.
Does EZZ Life Science Holdings Ltd pay a dividend?
EZZ Life Science Holdings Ltd has a dividend yield of 10.5%.
What does EZZ Life Science Holdings Ltd do?
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products.